Gaya Herald

Lupus Nephritis Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies – Roche, Novartis, AstraZeneca, Boehringer Ingelheim, and Others

 Breaking News
  • No posts were found

Lupus Nephritis Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies – Roche, Novartis, AstraZeneca, Boehringer Ingelheim, and Others

August 01
17:51 2022
Lupus Nephritis Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Roche, Novartis, AstraZeneca, Boehringer Ingelheim, and Others
Delveinsight Business Research LLP
Lupus Nephritis Market is expected to increase in the coming years owing to the launch of upcoming therapies, extensive research and development activities in the domain, and rising awareness, among others.

DelveInsight’s “Lupus Nephritis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Lupus Nephritis Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Lupus Nephritis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Lupus Nephritis Market

Lupus Nephritis: An Overview

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease and is the most common form of lupus that can affect multiple tissues and organs. The disease is characterized by producing antibodies to components of the cell nucleus associated with various clinical manifestations. The primary pathological findings in patients with SLE include inflammation, vasculitis, immune complex deposition, and vasculopathy.

Lupus Nephritis Market Key Facts

  • DelveInsight estimates that the total prevalent population of Lupus Nephritis in the 7 major markets was 192,000+ in 2018.

  • As per a study by McDonald L. et al., titled “Identifying Patients With Lupus Nephritis in the United Kingdom Clinical Practice Research Datalink”, (2017), suggests that the prevalence of SLE in the UK was 97 per 100 000, with 86% of observed cases being female. It is thought that the prevalence of LN in SLE patients is between 20-60%.

  • A study by Delarche A. et al., titled “Incidence and outcome of lupus nephritis in French Polynesia” (2018) stated that the annual incidence of SLE and LN in French Polynesia was 3.6 and 0.96 per 100,000,  respectively.

Lupus Nephritis Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Lupus Nephritis market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report details the Lupus Nephritis market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Lupus Nephritis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Lupus Nephritis Epidemiology Segmentation

  • Prevalent Population 

  • Gender-Specific Prevalent Population

  • Clinical Manifestations of Lupus Nephritis

  • Total Diagnosed Population

  • Class- Specific cases

Lupus Nephritis Drugs Uptake and Pipeline Development Activities

The drug uptake section focuses on the rate of uptake of the potential drugs recently launched in the Lupus Nephritis market or expected to be launched during the study period. The analysis covers Lupus Nephritis market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Lupus Nephritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Some of the key companies in the Lupus Nephritis Therapeutics Market include:

  • Roche

  • Novartis

  • AstraZeneca

  • Boehringer Ingelheim

And many others

Lupus Nephritis Therapies covered in the report include:

  • GAZYVA (Obinutuzumab; GA-101)

  • Anifrolumab (formerly MEDI-546)

  • BI 655064

  • Iscalimab

And many others

Overall, the increasing prevalence of Lupus Nephritis assisted by organizational support and the predicted approval of several promising emerging therapies, which are currently under late-stage development, are expected to fuel the Lupus Nephritis market size in the coming years.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Lupus Nephritis Competitive Intelligence Analysis

4. Lupus Nephritis Market Overview at a Glance

5. Lupus Nephritis Disease Background and Overview

6. Lupus Nephritis Patient Journey

7. Lupus Nephritis Epidemiology and Patient Population

8. Lupus Nephritis Treatment Algorithm, Current Treatment, and Medical Practices

9. Lupus Nephritis Unmet Needs

10. Key Endpoints of Lupus Nephritis Treatment

11. Lupus Nephritis Marketed Products

12. Lupus Nephritis Emerging Therapies

13. Lupus Nephritis Seven Major Market Analysis

14. Attribute Analysis

15. Lupus Nephritis Market Outlook (7 major markets)

16. Lupus Nephritis Access and Reimbursement Overview

17. KOL Views on the Lupus Nephritis Market.

18. Lupus Nephritis Market Drivers

19. Lupus Nephritis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.


Other Trending Healthcare Reports by DelveInsight

Dysthymia Market
“Dysthymia Market” research report provides a detailed overview of the historical and forecasted epidemiology and the Dysthymia Market size, share, and trends in the 7MM. Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics Market.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States